Literature DB >> 10604678

Total upper eyelid reconstruction with mucosalized tarsal graft and overlying bipedicle flap.

J R Patrinely1, K D O'Neal, R C Kersten, C N Soparkar.   

Abstract

Total or near-total upper eyelid reconstruction with a mucosalized tarsal graft and overlying bipedicled myocutaneous flap was performed on 12 patients. This technique offers several advantages over other reconstructive methods: (1) the opportunity for immediate visual rehabilitation through a single-staged procedure without obscuration of the visual axis, (2) preservation of eyelid blinking and closure by relocation of functional orbicularis muscle, (3) excellent eyelid contour, and (4) use of tissue physiologically similar to that removed. The technique and clinical results are presented herein.

Entities:  

Mesh:

Year:  1999        PMID: 10604678     DOI: 10.1001/archopht.117.12.1655

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Evaluation of the postoperative course of East Asian eyelid reconstruction with free tarsoconjunctival graft transplantation: A Japanese single-centre retrospective study.

Authors:  Jun Ominato; Tokuhide Oyama; Hiroyuki Cho; Naoya Shiozaki; Koichi Eguchi; Takeo Fukuchi
Journal:  JPRAS Open       Date:  2022-04-28

Review 2.  Advancements in the repair of large upper eyelid defects: A 10-year review.

Authors:  Erin Jennings; Mark Krakauer; William R Nunery; Vinay Kumar Aakalu
Journal:  Orbit       Date:  2020-09-29

3.  A modified method for upper eyelid reconstruction with innervated orbicularis oculi myocutaneous flaps and lower lip mucosal grafts.

Authors:  Sumiko Yoshitatsu; Makiko Shiraishi
Journal:  JPRAS Open       Date:  2021-03-24

4.  Total or subtotal replacement of tarsal plate by novel silicone plate for upper eyelid reconstruction in malignant tumors.

Authors:  Salil Kumar Mandal; Basupurna Majumdar; Purban Ganguly; Stephen C Dryden; James C Fleming; Brian T Fowler
Journal:  Indian J Ophthalmol       Date:  2021-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.